A $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at the University of Pennsylvania (Penn) and Children’s Hospital of Philadelphia (CHOP).
Risk Adjusted Net Present Value: What is the current valuation of Pfizer’s Ibuzatrelvir
The revenue for Ibuzatrelvir is expected to reach an annual total of $21 mn by 2036 in the US based off GlobalData’s Expiry Model. The